Document Detail


Riluzole use during pregnancy in a patient with amyotrophic lateral sclerosis: a case report.
MedLine Citation:
PMID:  20515588     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pregnancy with amyotrophic lateral sclerosis (ALS) is rare and generally considered dangerous. Riluzole is the only drug approved for use in ALS, but the effect on maternal and fetal health is unknown. We describe the case of an ALS patient taking riluzole throughout pregnancy. A 34-year old Japanese woman, who had been diagnosed with probable ALS 4 years earlier, visited our hospital for abdominal distension, without knowing that she was pregnant. The patient had been taking riluzole for 2 years, inclusive of her gestational months, and we decided to continue administration of the medication. The patient delivered a normal female infant transvaginally at 38 weeks gestation. The patient's neurological status was stable 1 year after delivery and the baby had developed normally. We found that, in this case, riluzole did not cause any side-effects to the pregnant woman or her fetus.
Authors:
Y Kawamichi; Y Makino; Y Matsuda; K Miyazaki; S Uchiyama; H Ohta
Related Documents :
21601198 - An alternative treatment option in tubal ectopic pregnancies with fetal heartbeat: aspi...
19763238 - Gastrointestinal stromal tumor in pregnancy: a case report.
10477048 - Morning sickness and salt intake, food cravings, and food aversions.
11013478 - Malrotation of the gut manifested during pregnancy.
11917228 - Extramedullary hematopoiesis in the endometrium.
12914428 - Aphaereta sp. (hymenoptera: braconidae: alysiinae) as a natural enemy to peckia chrysos...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of international medical research     Volume:  38     ISSN:  0300-0605     ISO Abbreviation:  J. Int. Med. Res.     Publication Date:    2010 Mar-Apr
Date Detail:
Created Date:  2010-06-02     Completed Date:  2010-07-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346411     Medline TA:  J Int Med Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  720-6     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Tokyo Women's Medical University, Shinjyuku-ku, Tokyo, Japan. yayokawa0227@yahoo.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amyotrophic Lateral Sclerosis / drug therapy*
Female
Fetal Monitoring
Humans
Infant, Newborn
Neuroprotective Agents / therapeutic use*
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy Outcome
Riluzole / therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Neuroprotective Agents; 1744-22-5/Riluzole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Calponin expression in laryngeal myoepithelial carcinoma and its prognostic implications: a case rep...
Next Document:  Challenges for rear hospital care of Wenchuan Earthquake casualties: experience from West China Hosp...